Wilson's disease: normalisation of cortically evoked motor responses with treatment
- PMID: 1940984
- DOI: 10.1007/BF00315332
Wilson's disease: normalisation of cortically evoked motor responses with treatment
Abstract
A newly diagnosed patient with Wilson's disease is reported in whom the only clearly pathological neurophysiological findings before treatment were abnormal electromyographic (EMG) responses evoked by transcranial magnetic brain stimulation. Serial examinations over 10 months following commencement of treatment with D-penicillamine revealed normalisation of EMG responses. Pathophysiologically, the initially abnormal EMG responses probably resulted from reversible impairment of impulse propagation along cortico-motor-neuronal pathways and/or a reduced excitability of cortical cells due to impaired function of the basal ganglia.
Similar articles
-
Abnormal conduction in corticospinal pathways in Wilson's disease: investigation of nine cases with magnetic brain stimulation.Mov Disord. 1991;6(4):320-3. doi: 10.1002/mds.870060409. Mov Disord. 1991. PMID: 1661845
-
Alterations of cortical excitability and central motor conduction time in Wilson's disease.Neurosci Lett. 2013 Oct 11;553:90-4. doi: 10.1016/j.neulet.2013.08.023. Epub 2013 Aug 21. Neurosci Lett. 2013. PMID: 23973307
-
Evoked potentials in assessment and follow-up of patients with Wilson's disease.Lancet. 1990 Oct 20;336(8721):963-4. doi: 10.1016/0140-6736(90)92419-i. Lancet. 1990. PMID: 1977004
-
Pathophysiology and treatment of Wilson's disease.Clin Pharm. 1991 Nov;10(11):839-49. Clin Pharm. 1991. PMID: 1794220 Review.
-
The development of cirrhosis in Wilson's disease.Clin Gastroenterol. 1975 May;4(2):367-79. Clin Gastroenterol. 1975. PMID: 1092490 Review. No abstract available.
Cited by
-
[Electrophysiological impairment profile of patients with Wilson's disease].Nervenarzt. 2003 Oct;74(10):881-7. doi: 10.1007/s00115-003-1564-8. Nervenarzt. 2003. PMID: 14551693 German.
-
Dopamine D2 receptor binding and cerebral glucose metabolism recover after D-penicillamine-therapy in Wilson's disease.J Neurol. 1994 Oct;241(10):577-84. doi: 10.1007/BF00920620. J Neurol. 1994. PMID: 7836960
-
Transcranial magnetic stimulation in children.Clin Neurophysiol. 2008 May;119(5):973-84. doi: 10.1016/j.clinph.2007.11.048. Epub 2008 Jan 24. Clin Neurophysiol. 2008. PMID: 18221913 Free PMC article. Review.
-
Transcranial magnetic stimulation in child neurology: current and future directions.J Child Neurol. 2008 Jan;23(1):79-96. doi: 10.1177/0883073807307972. Epub 2007 Dec 3. J Child Neurol. 2008. PMID: 18056688 Free PMC article. Review.
-
Effective Treatment of Neurological Symptoms with Normal Doses of Botulinum Neurotoxin in Wilson's Disease: Six Cases and Literature Review.Toxins (Basel). 2021 Mar 29;13(4):241. doi: 10.3390/toxins13040241. Toxins (Basel). 2021. PMID: 33805281 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical